Earlier investigations have shown that GLP-1 (Glucagon-like Peptide-1) analogs exhibit neuroprotective qualities in various models of neurological diseases, encompassing conditions such as Alzheimers disease, Parkinsons disease, and stroke
Future randomised controlled trials may provide clearer evidence, but clinicians and patients should be aware that the current evidence base does not support using these medications specifically to quit smoking outside of research settings
pmid:25521516 9
Linus Pauling Institute Oregon State University Updated in June 2014 by: Barbara Delage, Ph.D
Many over-the-counter (OTC) diet pills contain stimulants like caffeine, green tea extract, or yohimbine, which can have additive effects similar to phentermine because they may increase the risk of high blood pressure, rapid heart rate, anxiety, and other side effects